Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$116,367,508
+$23,032,928 QoQ
Shares Held
97,019
-4.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#354
of 4,605 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$1,327,999
PutShares
3,630
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Phoenix Financial Ltd. holds $174,300,668 across 10 Drug Manufacturers - General names. LLY ranks #1 (66.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
97,019 | $116,367,508 | |
| 2 | ABBV |
AbbVie Inc.
|
47,441 | $11,938,053 | |
| 3 | JNJ |
Johnson & Johnson
|
46,830 | $11,893,414 | |
| 4 | NVO |
Novo Nordisk A S
|
158,343 | $7,590,962 | |
| 5 | MRK |
Merck & Co., Inc.
|
52,551 | $6,752,803 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
114,254 | $6,583,314 | |
| 7 | PFE |
Pfizer Inc
|
253,976 | $6,115,741 | |
| 8 | AZN |
Astrazeneca PLC
|
19,365 | $3,671,991 |
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,367,508 | 97,019 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $93,334,580 | 101,476 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $34,451,019 | 32,057 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $27,950,216 | 36,632 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,424,233 | 31,332 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $20,556,073 | 24,889 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $14,696,564 | 19,037 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,008,709 | 16,941 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $15,916,579 | 17,580 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,030,103 | 10,322 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,151,846 | 8,838 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,410,775 | 6,350 | Shares | Sole | 2023-12-04 | |
| 2023-06-30 | $2,470,117 | 5,267 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,399,436 | 4,075 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,327,999 | 3,630 | Put | Sole | 2023-02-13 | |
| 2022-12-31 | $734,606 | 2,008 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $619,215 | 1,915 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $308,991 | 953 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||